128 related articles for article (PubMed ID: 38648896)
1. Efficacy and safety of withholding antimicrobial therapy in children with cancer, fever, and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial.
Torres JP; Ibañez C; Valenzuela R; Rivera S; De la Maza V; Villarroel M; Coria P; Contardo V; Álvarez AM; Zubieta CM; Gutierrez V; Ducasse K; Martínez D; Santolaya ME
Clin Microbiol Infect; 2024 Apr; ():. PubMed ID: 38648896
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial.
Santolaya ME; Alvarez AM; Acuña M; Avilés CL; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Zubieta M; Toso A; Bataszew A; Farfán MJ; de la Maza V; Vergara A; Valenzuela R; Torres JP
Clin Microbiol Infect; 2017 Mar; 23(3):173-178. PubMed ID: 27856269
[TBL] [Abstract][Full Text] [Related]
3. Frequency and clinical outcome of respiratory viral infections and mixed viral-bacterial infections in children with cancer, fever and neutropenia.
Torres JP; Labraña Y; Ibañez C; Kasaneva P; Farfán MJ; De la Maza V; Villarroel M; Vergara I; Piemonte P; Zubieta M; Salgado C; Tordecilla J; Topelberg S; O Ryan M; Santolaya ME
Pediatr Infect Dis J; 2012 Sep; 31(9):889-93. PubMed ID: 22565292
[TBL] [Abstract][Full Text] [Related]
4. Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.
Loeffen EA; Te Poele EM; Tissing WJ; Boezen HM; de Bont ES
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008382. PubMed ID: 26899263
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of step-down to oral outpatient treatment versus inpatient antimicrobial treatment in pediatric cancer patients with febrile neutropenia: A noninferiority multicenter randomized clinical trial.
Avilés-Robles MJ; Reyes-López A; Otero-Mendoza FJ; Valencia-Garin AU; Peñaloza-González JG; Rosales-Uribe RE; Muñoz-Hernández O; Garduño-Espinosa J; Juárez-Villegas L; Zapata-Tarrés M
Pediatr Blood Cancer; 2020 Jun; 67(6):e28251. PubMed ID: 32196898
[TBL] [Abstract][Full Text] [Related]
6. Respiratory Viral Infections and Coinfections in Children With Cancer, Fever and Neutropenia: Clinical Outcome of Infections Caused by Different Respiratory Viruses.
Torres JP; De la Maza V; Kors L; Villarroel M; Piemonte P; Izquierdo G; Salgado C; Tordecilla J; Contardo V; Farfán MJ; Mejías A; Ramilo O; Santolaya ME
Pediatr Infect Dis J; 2016 Sep; 35(9):949-54. PubMed ID: 27518750
[TBL] [Abstract][Full Text] [Related]
7. First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.
Brack E; Bodmer N; Simon A; Leibundgut K; Kühne T; Niggli FK; Ammann RA
Pediatr Blood Cancer; 2012 Sep; 59(3):423-30. PubMed ID: 22271702
[TBL] [Abstract][Full Text] [Related]
8. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial.
Santolaya ME; Alvarez AM; Acuña M; Avilés CL; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Zubieta M; Farfán M; de la Maza V; Vergara A; Valenzuela R; Torres JP
J Antimicrob Chemother; 2018 Oct; 73(10):2860-2866. PubMed ID: 30010931
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical outcome of respiratory viral infections among children with cancer and febrile neutropenia.
Meena JP; Brijwal M; Seth R; Gupta AK; Jethani J; Kapil A; Jat KR; Choudhary A; Kabra SK; Dwivedi SN; Dar L
Pediatr Hematol Oncol; 2019 Sep; 36(6):330-343. PubMed ID: 31512959
[No Abstract] [Full Text] [Related]
11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
12. Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial.
Santolaya ME; Alvarez AM; Aviles CL; Becker A; King A; Mosso C; O'Ryan M; Paya E; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
Pediatr Infect Dis J; 2008 Jun; 27(6):538-43. PubMed ID: 18458649
[TBL] [Abstract][Full Text] [Related]
13. Assessment of respiratory tract viruses in febrile neutropenic etiology in children and comparison with healthy children with upper/lower respiratory tract infection.
Turhan AB; Us T; Dinleyici EC; Yildirim GK; Kasifoglu N; Ozdemir ZC; Bor O
North Clin Istanb; 2021; 8(3):249-254. PubMed ID: 34222805
[TBL] [Abstract][Full Text] [Related]
14. Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT.
Coyle V; Forde C; Adams R; Agus A; Barnes R; Chau I; Clarke M; Doran A; Grayson M; McAuley D; McDowell C; Phair G; Plummer R; Storey D; Thomas A; Wilson R; McMullan R
Health Technol Assess; 2024 Mar; 28(14):1-101. PubMed ID: 38512064
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer.
Delebarre M; Gonzales F; Behal H; Tiphaine A; Sudour-Bonnange H; Lutun A; Abbou S; Pertuisel S; Thouvenin-Doulet S; Pellier I; Mansuy L; Piguet C; Paillard C; Blanc L; Thebaud E; Plantaz D; Blouin P; Schneider P; Guillaumat C; Simon P; Domenech C; Pacquement H; Le Meignen M; Pluchart C; Vérite C; Plat G; Martinot A; Duhamel A; Dubos F
Lancet Child Adolesc Health; 2022 Apr; 6(4):260-268. PubMed ID: 34871572
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: A prospective cohort.
Van de Wyngaert Z; Berthon C; Debarri H; Bories C; Bonnet S; Nudel M; Carpentier B; Legrand C; Barbieux S; Chauvet P; Simonnet A; Willaume A; Bossard JB; Renaud L; Wattebled KJ; Escure G; Branche N; Arib I; Titecat M; Quesnel B; Alfandari S
Int J Antimicrob Agents; 2019 Jun; 53(6):781-788. PubMed ID: 30831232
[TBL] [Abstract][Full Text] [Related]
18. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
[TBL] [Abstract][Full Text] [Related]
19. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.
Stern A; Carrara E; Bitterman R; Yahav D; Leibovici L; Paul M
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012184. PubMed ID: 30605229
[TBL] [Abstract][Full Text] [Related]
20. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
